Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review

Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review

provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that develops, manufactures and distributes diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.

Meridian Bioscience Inc Key Recent Developments

Feb 07,2020: Meridian Bioscience reports first quarter fiscal 2020 operating results and reaffirms 2020 guidance
Jan 23,2020: Meridian launched a new high-fidelity polymerase to offer robust amplification for NGS and PCR applications
Nov 07,2019: Meridian Bioscience reports fourth quarter and full-year fiscal 2019 operating results and provides fiscal 2020 guidance
Jul 30,2019: Meridian Bioscience reports third quarter 2019 operating results
May 24,2019: Meridian Bioscience announces entry into a material definitive agreement

Key benefits of buyi

ng this profile include:You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Meridian Bioscience Inc - Key Facts
Meridian Bioscience Inc - Key Employees
Meridian Bioscience Inc - Key Employee Biographies
Meridian Bioscience Inc - Major Products and Services
Meridian Bioscience Inc - History
Meridian Bioscience Inc - Company Statement
Meridian Bioscience Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Meridian Bioscience Inc - Business Description
Business Segment: Diagnostics
Overview
Performance
Business Segment: Life Science
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: ROW
Performance
Meridian Bioscience Inc - SWOT Analysis
SWOT Analysis - Overview
Meridian Bioscience Inc - Strengths
Meridian Bioscience Inc - Weaknesses
Meridian Bioscience Inc - Opportunities
Meridian Bioscience Inc - Threats
Meridian Bioscience Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Meridian Bioscience Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 07, 2020: Meridian Bioscience reports first quarter fiscal 2020 operating results and reaffirms 2020 guidance
Jan 23, 2020: Meridian launched a new high-fidelity polymerase to offer robust amplification for NGS and PCR applications
Nov 07, 2019: Meridian Bioscience reports fourth quarter and full-year fiscal 2019 operating results and provides fiscal 2020 guidance
Jul 30, 2019: Meridian Bioscience reports third quarter 2019 operating results
May 24, 2019: Meridian Bioscience announces entry into a material definitive agreement
May 01, 2019: Meridian Bioscience to buy GenePOC in $120m deal
Apr 30, 2019: Meridian Bioscience reports second quarter 2019 operating results
Apr 02, 2019: Meridian Bioscience announces preliminary second quarter 2019 revenue results; updates fiscal 2019 guidance
Feb 07, 2019: Meridian launches new range of Lyo-Ready PCR Mixes
Jan 24, 2019: Meridian Bioscience reports first quarter 2019 operating results, declares regular first quarter cash dividend, and provides updated fiscal 2019 guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Meridian Bioscience Inc, Key Facts
Meridian Bioscience Inc, Key Employees
Meridian Bioscience Inc, Key Employee Biographies
Meridian Bioscience Inc, Major Products and Services
Meridian Bioscience Inc, History
Meridian Bioscience Inc, Subsidiaries
Meridian Bioscience Inc, Key Competitors
Meridian Bioscience Inc, Ratios based on current share price
Meridian Bioscience Inc, Annual Ratios
Meridian Bioscience Inc, Annual Ratios (Cont...1)
Meridian Bioscience Inc, Annual Ratios (Cont...2)
Meridian Bioscience Inc, Interim Ratios
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Meridian Bioscience Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Meridian Bioscience Inc, Performance Chart (2015 - 2019)
Meridian Bioscience Inc, Ratio Charts
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook